Aurora Private Wealth Inc. bought a new position in shares of Koninklijke Philips N.V. (NYSE:PHG - Free Report) during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 66,726 shares of the technology company's stock, valued at approximately $1,695,000.
Other large investors have also bought and sold shares of the company. Colonial Trust Co SC boosted its position in shares of Koninklijke Philips by 724.0% during the 4th quarter. Colonial Trust Co SC now owns 1,409 shares of the technology company's stock worth $36,000 after purchasing an additional 1,238 shares in the last quarter. Farther Finance Advisors LLC raised its position in shares of Koninklijke Philips by 37.1% during the fourth quarter. Farther Finance Advisors LLC now owns 2,150 shares of the technology company's stock worth $54,000 after purchasing an additional 582 shares during the period. Whipplewood Advisors LLC acquired a new stake in Koninklijke Philips in the 4th quarter valued at $55,000. Millstone Evans Group LLC bought a new stake in Koninklijke Philips during the 4th quarter valued at $60,000. Finally, Smartleaf Asset Management LLC lifted its stake in shares of Koninklijke Philips by 177.4% in the fourth quarter. Smartleaf Asset Management LLC now owns 4,489 shares of the technology company's stock valued at $114,000 after buying an additional 2,871 shares in the last quarter. 13.67% of the stock is currently owned by institutional investors and hedge funds.
Koninklijke Philips Price Performance
Koninklijke Philips stock opened at $23.90 on Wednesday. The stock has a market cap of $23.01 billion, a P/E ratio of 55.59, a P/E/G ratio of 0.64 and a beta of 0.76. The company has a quick ratio of 0.79, a current ratio of 1.28 and a debt-to-equity ratio of 0.60. The company's 50 day moving average price is $23.69 and its two-hundred day moving average price is $25.09. Koninklijke Philips N.V. has a 52 week low of $20.61 and a 52 week high of $31.57.
Koninklijke Philips (NYSE:PHG - Get Free Report) last announced its quarterly earnings data on Tuesday, May 6th. The technology company reported $0.27 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.14 by $0.13. The firm had revenue of $4.31 billion during the quarter, compared to the consensus estimate of $4.10 billion. Koninklijke Philips had a return on equity of 10.97% and a net margin of 2.11%. The business's revenue for the quarter was down 1.0% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.21 EPS. On average, equities analysts predict that Koninklijke Philips N.V. will post 1.63 earnings per share for the current year.
Analyst Ratings Changes
A number of research firms recently weighed in on PHG. Sanford C. Bernstein upgraded shares of Koninklijke Philips from a "hold" rating to a "strong-buy" rating in a report on Tuesday, March 18th. BNP Paribas raised Koninklijke Philips from a "neutral" rating to an "outperform" rating in a research note on Tuesday, February 25th. Finally, Wall Street Zen lowered Koninklijke Philips from a "buy" rating to a "hold" rating in a report on Sunday, June 15th. Two research analysts have rated the stock with a hold rating, two have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy".
Check Out Our Latest Stock Analysis on PHG
Koninklijke Philips Profile
(
Free Report)
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
Featured Stories
Want to see what other hedge funds are holding PHG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Koninklijke Philips N.V. (NYSE:PHG - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Koninklijke Philips, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Koninklijke Philips wasn't on the list.
While Koninklijke Philips currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
